Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "human-trials"

23 News Found

Asahi Kasei pushes into human trials with new autoimmune drug candidate
Clinical Trials | April 22, 2026

Asahi Kasei pushes into human trials with new autoimmune drug candidate

The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp


Onchilles Pharma gets FDA green light for first-in-human trials of breakthrough cancer therapy
News | February 04, 2026

Onchilles Pharma gets FDA green light for first-in-human trials of breakthrough cancer therapy

N17350 is the company’s first-in-class tumor-directed therapeutic, designed to harness the ELANE pathway


Insilico Medicine’s AI-designed Parkinson’s drug cleared for human trials by FDA
Clinical Trials | January 29, 2026

Insilico Medicine’s AI-designed Parkinson’s drug cleared for human trials by FDA

The upcoming Phase I trial will test the safety, tolerability, and pharmacokinetics of ISM8969 in healthy volunteers and determine the optimal dosing for future studies


China nod to first homegrown BNCT cancer drug for human trials
R&D | January 20, 2026

China nod to first homegrown BNCT cancer drug for human trials

The injectable borofalan (10B), developed by CNNC Headway—a subsidiary of China Isotope & Radiation Corporation (CIRC) under the China National Nuclear Corporation (CNNC)—has officially entered Phase I clinical trials


Ceryx Medical raises £3.8m in seed funding to bring cardiac device to in-human trials
Startup | April 28, 2022

Ceryx Medical raises £3.8m in seed funding to bring cardiac device to in-human trials

Cysoni is a bionic device that paces the heart with real-time respiratory modulation


Novel preventive vaccine for Parkinson’s move into human trials
Biotech | January 12, 2022

Novel preventive vaccine for Parkinson’s move into human trials

MultiTEP Platform-based vaccine targeting three B cell epitopes of pathological ?-Synuclein simultaneously shows protective efficacy in mouse model of synucleinopathies


GlycoNex wins Japan nod to launch first human trial of lead program in gastrointestinal cancers
Clinical Trials | April 16, 2026

GlycoNex wins Japan nod to launch first human trial of lead program in gastrointestinal cancers

The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy


Veristat expands global trial & regulatory services as Chinese drugmakers push overseas
Clinical Trials | March 14, 2026

Veristat expands global trial & regulatory services as Chinese drugmakers push overseas

The expansion builds on Veristat’s work helping Chinese pharmaceutical firms such as Hansoh Pharma and CStone Pharmaceuticals


ProBioGen, Zag Bio seal manufacturing deal to fast-track type 1 diabetes therapy into clinic
Biotech | January 07, 2026

ProBioGen, Zag Bio seal manufacturing deal to fast-track type 1 diabetes therapy into clinic

The work will leverage ProBioGen’s CHO.RiGHT expression platform, powered by its proprietary DirectedLuck transposase technology, alongside PsiBot smart automation